We are committed to providing patient-focused, evidence-based care to all of our patients, pairing clinical expertise with the latest advances in technology. We offer a comprehensive range of imaging services, and tailor each exam to meet each patient’s specific needs. Our board-certified doctors are national and international leaders in diagnostic imaging and advanced image-guided therapies, and they are dedicated to maintaining the highest standards of care in patient safety, quality, and satisfaction. We employ a multidisciplinary approach to care, and collaborate with physicians from all medical specialties to make the most accurate diagnosis and determine the best treatment options. Yale patients have access to highly advanced imaging equipment, including an intraoperative MRI/IR/OR suite, and 3D tomosynthesis. Our radiologists conduct advanced research in MRI, MRS, PET, interventional oncology, and image processing. Specialized care is offered in the following areas: Abdominal imaging Breast imaging Cardiovascular imaging Emergency and trauma radiology Neuroradiology Nuclear medicine and molecular imaging (including PET/CT) Pediatric radiology Thoracic imaging Vascular/interventional radiology Rapid, in-house subspecialist imaging interpretations Overnight coverage by three in-house attending radiologists at Yale New Haven Hospital Leader in 3D tomosynthesis mammography imaging and research Leader in screening breast ultrasound Comprehensive multidisciplinary lung cancer screening program with ultra-low-dose CT scanning Cardiac CoreValue planning service, providing a minimally invasive transcatheter aortic valve implantation option for patients with severe aortic stenosis MRI for pacemaker patients Ultrasound contrast and elastography imaging Dedicated peripheral vascular ultrasound Integrated musculoskeletal ultrasound device Subspecialized pediatric interventional radiology expertise Recognized expertise in management of primary and secondary liver cancer Molecular imaging for recurrent prostate cancer and the diagnosis of Alzheimer’s disease Advanced tumor imaging for optimizing best treatment outcomes DaTscan, a diagnostic test for Parkinson’s Disease Portable neuro Intensive Care Unit (ICU) computed tomography (CT) scanning Interventional radiology with state-of-the-art minimally invasive image-guided therapy, including targeted and precision cancer treatments, back pain treatment, and biliary stone laser treatment, among others

Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute—and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.

A variety of diseases can affect the health of the kidneys. We care for patients at every stage of kidney disease, offering scientifically proven treatments and a personalized care plan. The Department of Urology is part of the Living Donor Transplant Program at the Yale New Haven Transplantation Center where we care for patients with renal disease who are candidates for kidney transplantation. We have expertise in performing laparoscopic, living-donor nephrectomies, delivering the highest quality care to the kidney donor-patient team at Yale. At Yale Medicine, our patients have full access to leading physicians who can help with all aspects of renal disease. Patients also have access to world-class resources at Smilow Cancer Hospital at Yale New Haven. Our doctors are at the forefront of kidney disease and kidney cancer treatment and research, including novel immunotherapy approaches and the genetic characterization of kidney cancers. In addition, the Yale School of Medicine's Hereditary Kidney Cancer and Genetic Assessment Program investigates potential genetic causes of kidney cancer in young patients, including those with a family history and individuals with multiple tumors, to help family members determine if they carry a risk for kidney cancer.